{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:47:02Z","timestamp":1784832422324,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2011,11,13]],"date-time":"2011-11-13T00:00:00Z","timestamp":1321142400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00520-011-1324-4","type":"journal-article","created":{"date-parts":[[2011,11,12]],"date-time":"2011-11-12T21:45:52Z","timestamp":1321134352000},"page":"2141-2147","source":"Crossref","is-referenced-by-count":9,"title":["The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy"],"prefix":"10.1007","volume":"20","author":[{"given":"Elvio G.","family":"Russi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco C.","family":"Merlano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmauro","family":"Numico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Corv\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Benasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Vigna-Taglianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Melano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerina","family":"Denaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pergolizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Colantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Lucio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Brizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,13]]},"reference":[{"key":"1324_CR1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0360-3016(00)01488-7","volume":"49","author":"PM Harari","year":"2001","unstructured":"Harari PM, Huang S (2001) Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys 49:427\u2013433","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1324_CR2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/cncr.24120","volume":"115","author":"A Tejwani","year":"2009","unstructured":"Tejwani A, Wu S, Jia Y et al (2009) Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy. Cancer 115:1286\u20131299","journal-title":"Cancer"},{"key":"1324_CR3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/1535-7163.MCT-04-0238","volume":"4","author":"CD Woodworth","year":"2005","unstructured":"Woodworth CD, Michael E, Marker D et al (2005) Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol Cancer Ther 4:650\u2013658","journal-title":"Mol Cancer Ther"},{"key":"1324_CR4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1365-2133.2001.04226.x","volume":"144","author":"K Busam","year":"2001","unstructured":"Busam K, Capodieci P, Motzer R et al (2001) Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol 144:1169\u20131176","journal-title":"Br J Dermatol"},{"key":"1324_CR5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.20.1.110","volume":"20","author":"J Albanell","year":"2002","unstructured":"Albanell J, Rojo F, Averbuch S et al (2002) Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition. J Clin Oncol 20:110\u2013124","journal-title":"J Clin Oncol"},{"key":"1324_CR6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","volume":"357","author":"W Budach","year":"2007","unstructured":"Budach W, Bolke E, Homey B (2007) Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med 357:514\u2013515","journal-title":"N Engl J Med"},{"key":"1324_CR7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ijrobp.2007.05.063","volume":"69","author":"EG Russi","year":"2007","unstructured":"Russi EG, Merlano MC, Comino A, Numico G (2007) Ultrathin hydrocolloid dressing in skin damaged from alternating radiotherapy and chemotherapy plus cetuximab in advanced head and neck cancer (G.O.N.O. AlteRCC Italian Trial): In Regard to Macmillan et al. (Int J Radiat Oncol Biol Phys 2007;68:864\u2013872). Int J Radiat Oncol Biol Phys 69:638\u2013639","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1324_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1188\/08.CJON.283-290","volume":"12","author":"B Eaby","year":"2008","unstructured":"Eaby B, Culkin A, Lacouture M (2008) An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors. Clin J Oncol Nurs 12:283\u2013290","journal-title":"Clin J Oncol Nurs"},{"key":"1324_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3747\/co.v16i1.361","volume":"16","author":"B Melosky","year":"2009","unstructured":"Melosky B, Burkes R, Rayson D et al (2009) Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations. Curr Oncol 16:16\u201326","journal-title":"Curr Oncol"},{"key":"1324_CR10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2008.09.018","volume":"90","author":"DI Pryor","year":"2009","unstructured":"Pryor DI, Porceddu SV, Burmeister BH et al (2009) Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 90:172\u2013176","journal-title":"Radiother Oncol"},{"key":"1324_CR11","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/annonc\/mdq412","volume":"22","author":"M Merlano","year":"2011","unstructured":"Merlano M, Russi E, Benasso M et al (2011) Cisplatin-based chemoradiation plus cetuximab in locally advanced head and neck cancer: a phase II clinical study. Ann Oncol 22:712\u2013717","journal-title":"Ann Oncol"},{"key":"1324_CR12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2010.05.018","volume":"81","author":"G Studer","year":"2011","unstructured":"Studer G, Brown M, Salgueiro EB et al (2011) Grade 3\/4 dermatitis in head and neck cancer patients treated with concurrent Cetuximab and IMRT. Int J Radiat Oncol Biol Phys 81:110\u2013117","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1324_CR13","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0360-3016(02)02756-6","volume":"53","author":"N Lee","year":"2002","unstructured":"Lee N, Chuang C, Quivey JM et al (2002) Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys 53:630\u2013637","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1324_CR14","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2006.08.8005","volume":"25","author":"D Curran","year":"2007","unstructured":"Curran D, Giralt J, Harari PM et al (2007) Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 25:2191\u20132197","journal-title":"J Clin Oncol"},{"key":"1324_CR15","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1002\/cncr.25090","volume":"116","author":"SS Joshi","year":"2010","unstructured":"Joshi SS, Ortiz S, Witherspoon JN et al (2010) Effects of epidermal growth factor receptor inhibitor-induced dermatologic toxicities on quality of life. Cancer 116:3916\u20133923","journal-title":"Cancer"},{"issue":"11 Suppl 5","key":"1324_CR16","first-page":"34","volume":"21","author":"LI Wagner","year":"2007","unstructured":"Wagner LI, Lacouture ME (2007) Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist\u2019s perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology (Williston Park) 21(11 Suppl 5):34\u201336","journal-title":"Oncology (Williston Park)"},{"key":"1324_CR17","volume-title":"AJCC cancer staging manual","author":"DL Page","year":"2002","unstructured":"Page DL, Fleming ID, Fritz A et al (2002) AJCC cancer staging manual, 6th edn. Springer, New York","edition":"6"},{"key":"1324_CR18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/88.9.583","volume":"88","author":"M Merlano","year":"1996","unstructured":"Merlano M, Benasso M, Corv\u00f2 R et al (1996) Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 88:583\u2013589","journal-title":"J Natl Cancer Inst"},{"key":"1324_CR19","unstructured":"Common Terminology Criteria for Adverse Events v3.0 (CTCAE), U.S. Department of Health and Human Services, National Institutes of Health National Cancer Institute (2006) https:\/\/webapps.ctep.nci.nih.gov\/webobjs\/ctc\/webhelp\/welcome_to_ctcae.htm . Accessed April 12, 2011"},{"key":"1324_CR20","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.12968\/bjon.1999.8.18.6490","volume":"8","author":"R Noble-Adams","year":"1999","unstructured":"Noble-Adams R (1999) Radiation-induced skin reactions. 2: development of a measurement tool. Br J Nurs 8:1208\u20131211","journal-title":"Br J Nurs"},{"key":"1324_CR21","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.12968\/bjon.1999.8.19.1305","volume":"8","author":"R Noble-Adams","year":"1999","unstructured":"Noble-Adams R (1999) Radiation-induced skin reactions. 3: evaluating the RISRAS. Br J Nurs 8:1305\u20131312","journal-title":"Br J Nurs"},{"key":"1324_CR22","doi-asserted-by":"crossref","first-page":"E8","DOI":"10.1097\/01.NCC.0000305680.06143.39","volume":"31","author":"SK MacBride","year":"2008","unstructured":"MacBride SK, Wells ME, Hornsby C et al (2008) A case study to evaluate a new soft silicone dressing, mepilex lite, for patients with radiation skin reactions. Cancer Nurs 31:E8\u2013E14","journal-title":"Cancer Nurs"},{"key":"1324_CR23","first-page":"135","volume-title":"Supportive care in radiotherapy","author":"M Wells","year":"2004","unstructured":"Wells M, MacBride S (2004) Radiation skin reactions. In: Faithful S, Wells M (eds) Supportive care in radiotherapy. Churchill Livingstone, Edinburgh, pp 135\u2013159"},{"key":"1324_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1\u201310","journal-title":"Control Clin Trials"},{"key":"1324_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","volume":"184","author":"E B\u00f6lke","year":"2008","unstructured":"B\u00f6lke E, Gerber PA, Lammering G et al (2008) Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab. Strahlenther Onkol 184:105\u2013110","journal-title":"Strahlenther Onkol"},{"key":"1324_CR26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.12968\/bjon.1999.8.17.6503","volume":"8","author":"R Noble-Adams","year":"1999","unstructured":"Noble-Adams R (1999) Radiation-induced reactions. 1: an examination of the phenomenon. Br J Nurs 8:1134\u20131140","journal-title":"Br J Nurs"},{"key":"1324_CR27","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.4049\/jimmunol.174.8.5047","volume":"174","author":"S Pastore","year":"2005","unstructured":"Pastore S, Mascia F, Mariotti F et al (2005) ERK1\/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 174:5047\u20135056","journal-title":"J Immunol"},{"key":"1324_CR28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/sj.jid.5701184","volume":"128","author":"S Pastore","year":"2008","unstructured":"Pastore S, Mascia F, Mariani V, Girolomoni G (2008) The epidermal growth factor receptor system in skin repair and inflammation. J Invest Dermatol 128:1365\u20131374","journal-title":"J Invest Dermatol"},{"key":"1324_CR29","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) and Common Toxicity Criteria (CTC) v. 4. U.S.Department of Health and Human Services, National Institutes of Health National Cancer Institute (2009) http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/About.html . Accessed July 10, 2010"},{"key":"1324_CR30","volume-title":"EORTC QLQ-C30 reference values","author":"P Fayers","year":"1998","unstructured":"Fayers P, Weeden S, Curran D, on behalf of the EORTC Quality of Life Study Group (1998) EORTC QLQ-C30 reference values. EORTC, Brussels"},{"key":"1324_CR31","unstructured":"National Cancer Institure, Center for Bioinformatics (2010) CTCAE: redesign and life cycle management. http:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/Documentation\/CTCAE_Governance_2010-03-11.pdf . Accessed 19 December 2010"},{"key":"1324_CR32","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/annonc\/mdr139","volume":"22","author":"J Bernier","year":"2011","unstructured":"Bernier J, Russi EG, Homey B et al (2011) Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. Ann Oncol 22:2191\u20132200","journal-title":"Ann Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1324-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-011-1324-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-011-1324-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:04:13Z","timestamp":1559095453000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-011-1324-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,13]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1007\/s00520-011-1324-4","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,13]]}}}